Cited by 57Sexual function and dysfunction studiesUrological Disorders and TreatmentsUrinary Bladder and Prostate Research

The Potential Role of Arginine Supplements on Erectile Dysfunction: A Systemic Review and Meta-Analysis

Rhim, Hye Chang, Kim, Min Seo, Park, Young-Jin, Choi, Woo Suk, Park, Hyoung Keun, Kim, Hyeong Gon, Kim, Aram, Paick, Sung Hyun·2019·The Journal of Sexual Medicine

Abstract

Introduction: The efficacy and safety of arginine supplements in erectile dysfunction (ED) remain debatable. Aim: To assess the potential role of arginine supplements on ED as alternatives to phosphodiesterase inhibitors. Methods: Studies published up to April 2018 that evaluated the efficacy of arginine supplements were identified from multiple databases (Google Scholar, PubMed, Medline, Embase, Kiss, DBpia, and Cochrane databases). Studies comparing arginine supplements with placebo or no treatment; focusing only on patients with mild to moderate severity of ED; and presenting outcomes such as improvement rate, International Index of Erectile Function (IIEF) score, and adverse effects were included. Subgroup analysis for arginine alone and arginine in combination with other substances was further conducted to increase interpretability. Main Outcome Measure: The strength of the association between arginine supplements and ED was assessed using relative odds ratios and weighted mean differences with 95% CI. Results: In total, 10 randomized controlled trials met the inclusion criteria, reporting the outcomes of 540 patients with ED. The analysis demonstrated that arginine supplements with dosage ranging from 1,500 to 5,000 mg significantly improved ED compared with placebo or no treatment (odds ratios, 3.37 [1.29, 8.77], P = .01, I2 = 44). Arginine supplements also caused significant improvements in the IIEF subdomain scores of overall satisfaction, intercourse satisfaction, orgasmic function, and erectile function, whereas the IIEF sexual desire score remain unchanged. The adverse effect rate in the arginine-treated group was 8.3%, and that in the placebo group was 2.3%, none of which were severe. Clinical Implications: Arginine supplements can be recommended to patients with mild to moderate ED. Strength & Limitations: The strength of this study is that it is the first meta-analysis to assess the potential role of arginine supplements in ED compared with placebo or no treatment. A limitation is that the treatment dosage and duration varied among studies, which may have contributed to study heterogeneity. Conclusion: The results of our systematic review and meta-analysis provide evidence on the effectiveness of arginine supplements for mild to moderate ED.

Integrity signals

Registry

Crossref · 10.1016/j.jsxm.2018.12.002

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rhim, H. C., Kim, M. S., Park, Y.-J., Choi, W. S., Park, H. K., Kim, H. G., Kim, A., & Paick, S. H.
Affiliations
  • Korea University (KR)
  • Konkuk University (KR)
Corresponding author
Paick, Sung Hyun
Venue
The Journal of Sexual Medicine
Published
2019-02-01
Volume
16
Issue
2
Pages
223-234
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2911617828
Cited by
57
References
51
Citations by year
2026: 6 · 2025: 11 · 2024: 9 · 2023: 10 · 2022: 9 · 2021: 9 · 2020: 3
FWCI
0.89
Type
journal article
Language
en
Update notices
erratum (2020-03-01)
Open access
closed
Locations
  • The Journal of Sexual Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
erectile dysfunction, phosphodiesterase inhibitors, International Index of Erectile Function, sexual function, adverse effects, alternative treatment, sexual desire, orgasmic function, intercourse satisfaction, study heterogeneity
MeSH terms
Arginine, Humans, Erectile Dysfunction, Male, Penile Erection, Phosphodiesterase Inhibitors, Randomized Controlled Trials as Topic, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review